Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
Kento UminoShin-Ichiro FujiwaraTakashi IkedaYumiko TodaShoko ItoKiyomi MashimaDaisuke MinakataHirofumi NakanoRyoko YamasakiYasufumi KawasakiMiyuki SugimotoChihiro YamamotoMasahiro AshizawaKaoru HatanoKazuya SatoIekuni OhKen OhmineKazuo MuroiYoshinobu KandaPublished in: Hematology (Amsterdam, Netherlands) (2018)
The further accumulation of clinical data is needed to determine the optimal therapeutic approach for these neoplasms.